Table 1 Specifications of the included studies in this meta-analysis
From: Evaluation of the association between KIR polymorphisms and systemic sclerosis: a meta-analysis
Author (Ref) | Published Year | Country/Race | Detection Technique | SSc Patients | Controls | KIR Polymorphisms |
|---|---|---|---|---|---|---|
N | N | |||||
T. Momot [1] | 2004 | Germany/Caucasian | PCR | 102 | 100 | 2DL1, 2DL2, 2DL3, 2DS1, 2DS2, 2DS3, 2DS4, 3DS1, 3DL1 |
P. H. Salim [2] | 2013 | Brazilian/Caucasian | PCR | 115 | 115 | 2DL1, 2DL2, 2DL3, 2DL4, 2DL5, 2DS1,2DS2, 2DS3, 2DS4, 2DS5, 3DL1, 3DL2, 3DL3, 3DS1, 2DP1 |
JD. Tozkır [3] | 2016 | Turkey/Edirne | PCR-SSP | 25 | 40 | 2DL1, 2DL2, 2DL3, 2DL4, 2DL5, 2DL5A, 2DL5B, 2DS1, 2DS2, 2DS3, 2DS4, 2DS5, 3DL1, 3DL2, 3DL3, 3DS1, 2DP1, 3DP1 |
M. Mahmoudi [4] | 2017 | Iranian/Caucasian | PCR-SSP | 279 | 451 | 2DL1, 2DL2, 2DL3, 2DL4, 2DL5, 2DL5A, 2DL5B, 3DL1, 3DL2, 3DL3, 2DS1, 2DS2, 2DS3, 2DS4, 2DS4 (full), 2DS4 (var), 2DS5, 3DS1, 2DP1, 3DP1, 3DP1 (full), 3DP1 (var) |
AC. Machado-Sulbaran [5] | 2019 | Mexico | PCR-SSP | 50 | 90 | 2DL1, 2DL2, 2DL3, 2DL4, 2DL5, 2DS1, 2DS2, 2DS3, 2DS4, 2DS5, 3DL1, 3DL2, 3DL3, 3DS1, 2DP1, 3DP1 |